6820 Assessing The Efficacy And Safety Of Setrusumab For Osteogenesis Imperfecta: Updated Phase 2 Data From The Phase 2/3 Orbit Study
Gottesman G, Carpenter T, Wallace M, Smith P, Imel E, Wang H, Byers H, Krolczyk S, Lewiecki E. 6820 Assessing The Efficacy And Safety Of Setrusumab For Osteogenesis Imperfecta: Updated Phase 2 Data From The Phase 2/3 Orbit Study. Journal Of The Endocrine Society 2024, 8: bvae163.358. PMCID: PMC11454541, DOI: 10.1210/jendso/bvae163.358.Peer-Reviewed Original Research